Pete Najarian Sees Unusual Options Activity In Intel And Centene
On CNBC's "Fast Money Halftime Report," Pete Najarian said that he bought calls in Intel Corporation (NASDAQ: INTC) on Tuesday.
Centene To Pay $143.3M To Settle Ohio, Mississippi Suit Over Double-Billing On Medicaid Drugs
Centene Corporation (NYSE:CNC) has agreed to pay Ohio $88.3 million to settle a lawsuit accusing the company of making off with…
Centene to Pay $88M to Ohio and $55M to Mississippi to Resolve Claims Made by the States Related to Services Provided by Envolve Pharmacy Solutions
Additionally, the Company is in discussions with a plaintiff's group led by the law firms of Liston & Deas and Cohen & Milstein in an effort to bring final resolution to these concerns in other affected
Shares Of Pharmacy/Healthcare Stocks Quiet As Traders Circulate Statement From FTC Commissioner Dated Friday That Criticizes Pharmacy Benefits Manager Industry, Is Calling For FTC, Congress To Take Steps To Address Issues In Industry
https://www.ftc.gov/system/files/documents/public_statements/1590528/statement_of_commissioner_rohit_chopra_regarding_the_commissions_report_on_pharmacy_benefit_manager.pdf
Wells Fargo Initiates Coverage On Centene with Overweight Rating, Announces Price Target of $87
Wells Fargo analyst Stephen Baxter initiates coverage on Centene (NYSE:CNC) with a Overweight rating and announces Price Target of $87.